Brittanny Groover: Melanoma Survivor

Brittanny Groover: Melanoma Survivor
[wpb_childpages]

What it Feels Like to be a Skin Cancer Survivor

Cancer, a word that strikes fear into the hearts of many. Skin cancer is a disease that affects millions of people worldwide, and its impact goes far beyond just physical health. The emotional and psychological toll it takes on patients and their loved ones cannot be understated. However, amidst the darkness, there is light – the power of sharing your cancer story with other patients.

When diagnosed with skin cancer, one can feel isolated and alone. It is easy to believe that no one else understands what you are going through. But by sharing your story with others who are experiencing similar journeys, you are helping to create a sense of community and support that can be invaluable in navigating this difficult path.

Reading about someone’s journey from diagnosis to remission can provide reassurance that there is light at the end of the tunnel. It serves as a reminder that even in the darkest times when all seems lost; there are stories of resilience and survival that offer solace during moments of despair.

By sharing your journey, you also become an advocate for awareness and education about this disease. Your experience holds immense value in raising public consciousness about early detection methods.

Sharing your cancer story is a powerful tool that fosters connection, inspires hope, and advocates for awareness. Let your voice be heard – share your story and make a difference in the lives of those fighting skin cancer.

You can also share your own story here.

Featured image for “Exploring Strategies for Home Skin Checks Tailored for Someone with Limited Mobility”

Exploring Strategies for Home Skin Checks Tailored for Someone with Limited Mobility

By Krista Rubin, MS, FNP-BC For many older adults, traditional skin self-exams become difficult over time. Arthritis, spinal stiffness, poor…

Kathleen Lowe

Featured image for “The FDA Just Approved a New Sunscreen Ingredient— What It Means for Patients with Skin Cancer, Survivors, and the General Public”

The FDA Just Approved a New Sunscreen Ingredient— What It Means for Patients with Skin Cancer, Survivors, and the General Public

For anyone living with a history of skin cancer—or working to prevent it—sun protection shouldn’t be just a summer habit. That’s why today’s announcement from the U.S.…

Kathleen Lowe

Featured image for “Why Are Young People Tanning Again? What a New allure Feature Reveals About Melanoma Prevention Challenges”

Why Are Young People Tanning Again? What a New allure Feature Reveals About Melanoma Prevention Challenges

A recent feature in allure magazine explores a concerning trend: The resurgence of tanning culture among younger generations. The article examines how…

Kathleen Lowe

Featured image for “What Patients Should Know About the Rising Rates of Skin Cancer”

What Patients Should Know About the Rising Rates of Skin Cancer

Skin cancer is becoming more common, especially among older adults who have spent decades working outdoors, gardening, golfing, walking, driving,…

Kathleen Lowe

Featured image for “SkylineDx to Present Data on Precision Molecular Diagnostics Advances in Cutaneous Squamous Cell Carcinoma at 22nd EADO Congress  ”

SkylineDx to Present Data on Precision Molecular Diagnostics Advances in Cutaneous Squamous Cell Carcinoma at 22nd EADO Congress  

New gene-signature for cutaneous squamous cell carcinoma (CSCC) demonstrates ability to identify a subset of patients with higher risk of developing…

Kathleen Lowe

Featured image for “Regeneron Announces Approval of Cemiplimab-rwlc for Adjuvant Treatment of Cutaneous Squamous-Cell Carcinoma with a High Risk of Recurrence After Surgery and Radiation    ”

Regeneron Announces Approval of Cemiplimab-rwlc for Adjuvant Treatment of Cutaneous Squamous-Cell Carcinoma with a High Risk of Recurrence After Surgery and Radiation    

The first and only FDA-approved immunotherapy for this patient population October 8, 2025 (Sacramento, California) The FDA has approved the…

Kathleen Lowe